版本:
中国

BRIEF-Nymox expects submission of initial filing seeking approval for Fexapotide Triflutate in next few weeks

March 29 Nymox Pharmaceutical Corp:

* Nymox provides update on Fexapotide development

* "Now expects to submit its initial filing seeking approval for Fexapotide Triflutate in next few weeks" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐